Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocugen (OCGN) Common Equity (2016 - 2025)

Ocugen (OCGN) has disclosed Common Equity for 12 consecutive years, with $3.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity fell 91.3% year-over-year to $3.5 million, compared with a TTM value of $3.5 million through Sep 2025, down 91.3%, and an annual FY2024 reading of $29.6 million, down 26.95% over the prior year.
  • Common Equity was $3.5 million for Q3 2025 at Ocugen, up from $3.1 million in the prior quarter.
  • Across five years, Common Equity topped out at $131.1 million in Q1 2022 and bottomed at $3.1 million in Q2 2025.
  • Average Common Equity over 5 years is $59.5 million, with a median of $49.8 million recorded in 2023.
  • The sharpest move saw Common Equity skyrocketed 696.07% in 2021, then crashed 91.3% in 2025.
  • Year by year, Common Equity stood at $91.2 million in 2021, then decreased by 18.88% to $74.0 million in 2022, then plummeted by 45.17% to $40.6 million in 2023, then dropped by 26.95% to $29.6 million in 2024, then crashed by 88.08% to $3.5 million in 2025.
  • Business Quant data shows Common Equity for OCGN at $3.5 million in Q3 2025, $3.1 million in Q2 2025, and $15.9 million in Q1 2025.